SOSV
SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995. It specializes in early-stage investments, focusing on deep technology innovations that address human and planetary health. The firm operates startup development programs, notably HAX and IndieBio, which provide resources, facilities, and lab equipment to accelerate the growth of promising startups. SOSV supports companies from their inception through various funding stages, including seed and series A rounds, while offering ongoing assistance to help them scale and attract additional investors. By concentrating on revolutionary technologies and cross-border markets, particularly in Asia, SOSV aims to foster significant advancements that benefit humanity and the environment.
Hemoalgae
Pre Seed Round in 2017
Hemoalgae is a biotechnology company based in Cartago, Costa Rica, established in 2016. It specializes in the production of hirudin, a natural anticoagulant derived from an improved microalgae strain. This innovative process enables the generation of valuable compounds that have significant medical applications, including treatment for coronary ischemic syndromes, disseminated intravascular coagulation, and thrombosis prophylaxis in both preoperative and postoperative settings. By leveraging genetic engineering tools, Hemoalgae aims to provide sustainable and cost-effective alternatives to traditionally sourced proteins and compounds, such as hirudin, which is typically obtained from leeches. The company's focus on microalgae positions it as a leader in developing bio-based solutions in the biotechnology sector.
Magenta Biolabs
Seed Round in 2016
Magenta BioLabs, founded in 2016 and located in Alajuela, Costa Rica, specializes in manufacturing hyaluronic acid for the cosmetic industry. The company focuses on transforming organic by-products from agriculture and other industries into high-quality raw materials. By employing a sustainable and environmentally friendly approach, Magenta BioLabs up-cycles these nutrient-rich by-products, creating a circular supply chain that promotes the continuous reuse and repurposing of materials. This innovative process enables the production of not only hyaluronic acid but also various other valuable compounds, contributing to a more sustainable cosmetic industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.